Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for SYK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.261B
March 31, 2026 581.00M
December 31, 2025 2.143B
September 30, 2025 1.54B
June 30, 2025 1.111B
March 31, 2025 250.00M
December 31, 2024 1.931B
September 30, 2024 1.474B
June 30, 2024 633.00M
March 31, 2024 204.00M
December 31, 2023 1.528B
September 30, 2023 1.05B
June 30, 2023 688.00M
March 31, 2023 445.00M
December 31, 2022 1.003B
September 30, 2022 889.00M
June 30, 2022 529.00M
March 31, 2022 203.00M
December 31, 2021 1.00B
September 30, 2021 933.00M
June 30, 2021 878.00M
March 31, 2021 452.00M
December 31, 2020 1.237B
September 30, 2020 829.00M
June 30, 2020 620.00M
Date Value
March 31, 2020 591.00M
December 31, 2019 735.00M
September 30, 2019 629.00M
June 30, 2019 514.00M
March 31, 2019 313.00M
December 31, 2018 1.046B
September 30, 2018 618.00M
June 30, 2018 649.00M
March 31, 2018 297.00M
December 31, 2017 679.00M
September 30, 2017 79.00M
June 30, 2017 650.00M
March 31, 2017 151.00M
December 31, 2016 751.00M
September 30, 2016 493.00M
June 30, 2016 468.00M
March 31, 2016 203.00M
December 31, 2015 671.00M
September 30, 2015 -509.00M
June 30, 2015 357.00M
March 31, 2015 380.00M
December 31, 2014 675.00M
September 30, 2014 535.00M
June 30, 2014 366.00M
March 31, 2014 206.00M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 1.061B
Zimmer Biomet Holdings, Inc. 447.80M
Edwards Lifesciences Corp. 651.90M
Abbott Laboratories 2.488B
Boston Scientific Corp. 1.474B